Equities

Poseida Therapeutics Inc

Poseida Therapeutics Inc

Actions
  • Price (USD)3.08
  • Today's Change0.270 / 9.61%
  • Shares traded671.29k
  • 1 Year change-8.61%
  • Beta0.3549
Data delayed at least 15 minutes, as of Mar 27 2024 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Century Therapeutics Inc2.24m-136.67m276.77m152.00--1.39--123.84-2.30-2.300.03773.060.0053----14,703.95-32.26---34.19-------6,115.12------0.00---57.01---4.38------
Compass Therapeutics Inc.0.00-42.49m282.06m32.00--1.76-----0.3343-0.33430.001.160.00----0.00-23.84-41.75-25.56-46.41------------0.00-------8.33---56.91--
Xeris Biopharma Holdings Inc163.91m-62.26m286.53m377.00------1.75-0.4525-0.45251.19-0.04910.49140.90124.68434,785.20-18.66-43.60-24.99-56.5782.5278.23-37.98-143.081.23-2.011.04--48.68131.5034.23--8.43--
Poseida Therapeutics Inc64.70m-123.43m297.19m330.00--2.84--4.59-1.38-1.380.71751.080.2068--7.15196,069.70-39.45-40.70-49.32-47.72-----190.76-233.49---14.930.361---50.42---92.85--19.01--
Verastem Inc0.00-87.37m298.99m73.00--5.21-----4.07-4.070.003.110.00----0.00-71.39-62.70-88.82-75.18-------406.17----0.3379---100.00---18.36------
Fennec Pharmaceuticals Inc13.05m-20.22m299.74m36.00------22.97-0.7598-0.75980.4907-0.39540.5279----362,555.60-81.79-69.00-94.92-76.0894.94---154.92-4,799.534.39-5.461.73-------36.71------
Petro Usa Inc0.00-33.38k300.20m-----------0.0002-0.00020.00-0.00080.00-------19,074.29-192,120.00---------------118.21---------81.58------
AC Immune SA16.38m-60.01m300.57m133.00--1.69--18.35-0.7102-0.71020.19291.790.0803--1.92123,144.50-29.41-18.25-31.56-19.52-----366.41-148.29---89.520.0213--276.1415.5223.35---15.49--
Adverum Biotechnologies Inc3.60m-117.17m304.27m121.00--1.78--84.52-11.62-11.620.35718.230.015----29,752.07-48.68-36.39-55.24-39.04-----3,254.58-5,279.60----0.00----17.4324.18---0.0247--
Inovio Pharmaceuticals Inc832.01k-135.12m304.52m122.00--2.53--366.00-6.12-6.120.03755.150.0032--0.97786,819.75-52.02-59.52-71.11-71.29-----16,239.87-4,097.36----0.125---91.89-51.3351.71---31.22--
Sutro Biopharma Inc153.73m-106.79m307.84m302.00--2.01--2.00-1.79-1.792.562.450.3503--7.12509,043.00-24.34-25.48-29.77-29.75-----69.47-113.71----0.0264--126.8431.9610.41--22.61--
Rapt Therapeutics Inc0.00-116.80m310.74m131.00--2.09-----3.05-3.050.004.270.00----0.00-53.15-46.30-57.90-49.97-------3,522.72----0.00---100.00---39.31---20.31--
Erasca Inc0.00-125.04m311.24m126.00--0.9828-----0.8327-0.83270.002.100.00----0.00-27.48---29.94--------------0.00------48.50------
Procaps Group SA414.10m52.20m313.65m5.50k5.347.964.500.75740.52090.52094.160.34910.8541.873.3875,290.1810.77--19.01--55.04--12.61--0.9861--0.8829--0.0434--142.18------
Data as of Mar 27 2024. Currency figures normalised to Poseida Therapeutics Inc's reporting currency: US Dollar USD

Institutional shareholders

38.13%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 202314.32m14.98%
Pentwater Capital Management LPas of 31 Dec 20235.98m6.25%
BlackRock Fund Advisorsas of 31 Dec 20234.39m4.59%
SilverArc Capital Management LLCas of 31 Dec 20233.71m3.88%
The Vanguard Group, Inc.as of 31 Dec 20232.85m2.98%
Geode Capital Management LLCas of 31 Dec 20231.52m1.59%
SSgA Funds Management, Inc.as of 31 Dec 20231.38m1.44%
Aisling Capital Management LPas of 31 Dec 20231.04m1.09%
William Blair Investment Management LLCas of 31 Dec 2023682.74k0.71%
Millennium Management LLCas of 31 Dec 2023592.58k0.62%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.